Abstracts Keynote & Plenary
Abstracts Keynote & Plenary
Abstracts Keynote & Plenary
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
clinical data [2]. Furthermore, various regimes of Denosumab and Pamidronate including combination<br />
treatments are explored based on the optimized model.<br />
(1). Marathe, A., M.C. Peterson, and D.E. Mager, Integrated Cellular<br />
Bone Homeostasis Model for Denosumab Pharmacodynamics in Multiple<br />
Myeloma Patients. The<br />
Journal of Pharmacology and Experimental Therapeutics, 2008. 326(2): p. 555-562.<br />
⑵. Body, J.‐J., et al., A Study of the Biological Receptor Activator of Nuclear Factor‐KB Ligand<br />
Inhibitor, Denosumab, in Patients with Multiple Myeloma or Bone Metastases from Breast Cancer.<br />
Clin Cancer Res, 2006. 12(4): p. 1221‐1228OR-009<br />
Computational approach towards promoter sequence comparison via TF mapping Using a new<br />
distance measure<br />
Meera A*, Lalitha Rangarajana,<br />
Savithri Bhat1<br />
B.M.S College of Engineering, Bull temple road, Bangalore- 560 019, India<br />
Department of Computer Science, University of Mysore, Mysore, India,<br />
Author for correspondence, Tel : 91-080-26622130, Extn 3029, fax: 91-080-26614357,<br />
Email: savithri.bhat@gmail.com<br />
We propose a method for identifying TFBS in the given Promoter sequence and mapping the<br />
Transcription factors (TFs). The proposed algorithm searches the +1Transcription start site (TSS) for<br />
eukaryotic and prokaryotic sequences individually. The algorithm was tested with sequences from both<br />
eukaryotes and prokaryotes for at least 9 experimentally verified and validated functional TFs in<br />
promoter sequences. The order and type of TF binding to the promoter of genes encoding CMP enzyme<br />
was tabulated. A new similarity measure was devised for scoring the similarity between a pair of<br />
promoter sequences based on the number and order of motifs. Further, these were grouped in clusters<br />
considering the scores between them. The distances between each of the clusters in individual pathway<br />
was calculated and a phylogenetic tree was developed. This method is being further applied to other<br />
pathways such as lipid and amino acid biosynthesis to retrieve and compare experimentally verified<br />
and conserved TFBs.<br />
Keywords: Promoter sequence,<br />
Phylogeny, Database, Central Metabolic Pathway, pattern matching,<br />
Transcription factors (TFs), Transcription factor binding sites(TFBS), similarity measure, Cluster.<br />
OR-010<br />
MultiScale Modeling of Immunotoxin Efficacies in Vascular Tumors<br />
Kevin C. Chen , and Liang Li<br />
Shantou University, Shantou, Guangdong,<br />
515063, China<br />
One of the major setbacks in cancer chemotherapy is the inability<br />
to distinguish malignant cells from<br />
normal ones. Consequently, any anticancer therapy that can target only malignant cells would be a<br />
significant improvement. The use of recombinant immunotoxins (RITs) to target antigens uniquely or<br />
overwhelmingly expressed on cancer cells has become a promising strategy. Based on our previous<br />
work [1], in this study we applid modeling approach to explore the effects of various physiological and<br />
biological functions of RITs on their antitumor efficacies. Specifically, we included the neogenesis and<br />
destruction of tumor vasculatires in our simulations to study their correlations with tumor growth and<br />
resistance to anticancer drugs. We studied different RITs based on Pseudomonas exotoxin (PE) -fused<br />
recombinaant proteins (Fig. 1). In order to incorporate spatial heterogeneity and increased biological<br />
realism, we employed a more computationally challenging scheme based on cellular automata (CA)<br />
called the Cellular Potts Model (CPM) which allows us to treat cells as autonomous agents and to<br />
construct rules based on the local microenvironment (e.g., see [3]). The original Potts model [4],